A detailed history of Hanseatic Management Services Inc transactions in Care Dx, Inc. stock. As of the latest transaction made, Hanseatic Management Services Inc holds 17,277 shares of CDNA stock, worth $400,653. This represents 0.51% of its overall portfolio holdings.

Number of Shares
17,277
Previous 24,998 30.89%
Holding current value
$400,653
Previous $780,000 52.69%
% of portfolio
0.51%
Previous 1.11%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 15, 2025

SELL
$20.4 - $32.2 $157,508 - $248,616
-7,721 Reduced 30.89%
17,277 $369,000
Q3 2024

Oct 31, 2024

BUY
$14.41 - $33.99 $360,221 - $849,682
24,998 New
24,998 $780,000
Q4 2021

Feb 09, 2022

SELL
$41.2 - $73.6 $3,914 - $6,991
-95 Closed
0 $0
Q4 2020

Jan 29, 2021

BUY
$41.43 - $77.09 $3,935 - $7,323
95 New
95 $7,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.24B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Hanseatic Management Services Inc Portfolio

Follow Hanseatic Management Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hanseatic Management Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Hanseatic Management Services Inc with notifications on news.